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The carbapenem-hydrolyzing class D -lactamase OXA-253 was identiﬁed in an Acinetobacter baumannii clinical isolate be-
longing to sequence type 113 (ST113) in Brazil. OXA-253 shares 93.8% amino acid identity with OXA-143. The blaOXA-253 gene is
located on a ca. 20-kb plasmid. The genetic environment of the blaOXA-253 gene shares the highest identity with ubiquitous GR2
group plasmids usually carrying blaOXA-24/-40 genes.
Acinetobacter baumannii strains are frequently associated withnosocomial infections, and their resistance to carbapenems
has risen in recent decades (1, 2). The main mechanisms of resis-
tance to carbapenems of A. baumannii are efﬂux pumps, porin
mutations, overexpression of the chromosomally encoded OXA-
51-like -lactamase, and the biosynthesis of acquired carbap-
enem-hydrolyzing class D -lactamases (CHDLs) (oxacillinases)
(3). To date, ﬁve main groups of CHDLs have been identiﬁed in A.
baumannii, the intrinsic chromosomally encoded OXA-51-like
enzyme and the acquired chromosomally encoded and plasmid-
encoded OXA-23-like, OXA-40-like, OXA-58-like, and OXA-
143-like enzymes (3). OXA-143 was ﬁrst described in 2009 from
an A. baumannii strain isolated in Brazil in 2004 (2). In this study,
we report an A. baumannii clinical strain producing OXA-253, a
variant of OXA-143. The genetic environment of the plasmid-
borne blaOXA-253 gene is detailed.
The clinical isolate A. baumannii 25 was recovered from a per-
ineal swab in the intensive care unit in Minas Gerais Hospital,
Brazil. MICs were determined by Etest (bioMérieux, La Balme-
les-Grottes, France). Isolate 25 was resistant to all -lactams, in-
cluding carbapenems, and had reduced susceptibility to cefepime
according to the CLSI guidelines (4) (Table 1). It was also resistant
to ﬂuoroquinolones (ciproﬂoxacin), and susceptible to aminogly-
cosides (gentamicin, tobramycin, amikacin, and netilmicin), and
tetracycline. A modiﬁed version of the CarbaNP test (5) and the
CarbAcinetoNP test (P. Nordmann, personal communication)
was performed and showed a carbapenemase activity. PCR exper-
iments, performed as previously described for screening of
blaOXA-23, blaOXA-40, blaOXA-58 and blaOXA-143 genes (6), identiﬁed
a blaOXA-143-like gene. Further sequencing of the PCR product
identiﬁed the blaOXA-253 gene (GenBank number KC479324) and
showed 95% nucleotide identity with the blaOXA-143 gene. The
deduced protein sequence showed 17 amino acid differences be-
tween OXA-143 and OXA-253 (93.8% identity) (Fig. 1). Those
amino acid changes do not occur in the conserved residues STFK
(position 70 to 73) and KSG (position 216 to 218) of class D
-lactamases or in the FGN structural element (position 144 to
146) of carbapenem-hydrolyzing class D -lactamases (CHDLs)
(Fig. 1).
Plasmid extraction from A. baumannii 25 performed by the
Kieser technique yielded two plasmids of ca. 70 and 20 kb (7). The
gene encoding the OXA-253 determinant from A. baumannii 25
was transferred to Escherichia coli TOP10 by electroporation. The
resulting E. coli TOP10 strain harboring the plasmid of ca. 20 kb
(pAb25) was selected on ticarcillin (50 g/ml) containing Trypti-
case soy agar. Plasmid DNA from E. coli TOP10 (pAb25) was used
as the template for sequencing the 3.59-kb sequence encompass-
ing the blaOXA-253 gene by primer walking, i.e., by using primers
sequentially designed on the obtained sequence from the inside of
the blaOXA-253 gene to the outside. Surprisingly, the genetic envi-
ronment of the blaOXA-253 gene, with the open reading frames
(ORFs) tonB, ORF2, ORF1, repAci2, and repB, differed greatly
from that of the blaOXA-143 gene described previously (2) but
showed 95% identity with that of the blaOXA-24/-40 gene of
pABVA01 plasmid (GR2 group) from an A. baumannii strain
from Italy (8), although the blaOXA-253 gene shares only 88% nu-
cleotide identitywith the blaOXA-24/-40 gene (Fig. 2). The blaOXA-253
genewasmost probably integrated via the XerC/XerD recognition
site, located between the blaOXA-253 gene and the replicase-coding
gene repAci2, as recently described for other GR2 group plasmids
carrying blaOXA-24/-40-like genes in A. baumannii isolates (9) (Fig.
2). The integration of the blaOXA-253 gene on this ubiquitous plas-
mid may facilitate the dissemination of this carbapenemase. In
order to determine the role of OXA-253 in the carbapenem resis-
tance of A. baumannii isolate 25, the natural plasmid harboring
the blaOXA-253 gene was electroporated into the A. baumannii ref-
erence strain CIP 7010, and MICs of -lactams for the resulting
strain A. baumannii CIP 7010(pOXA-253) were determined by
Etest (Table 1). MICs of carbapenems were the same for A. bau-
mannii CIP 7010(pOXA-253) and for A. baumannii 25, conﬁrm-
ing that OXA-253 on its own was able to confer carbapenem re-
sistance.
In order to compare the -lactam resistance proﬁle conferred
by each oxacillinase, OXA-143 and OXA-253 were produced in
the same genetic background. The PCR amplicon encompassing
Address correspondence to Delphine Girlich, dgirlich@yahoo.fr.
1
Published in $QWLPLFURELDO$JHQWVDQG&KHPRWKHUDS\±
which should be cited to refer to this work.
ht
tp
://
do
c.
re
ro
.c
h
the entire sequence of the blaOXA-143 genewas obtainedwith prim-
ers OXA-143A (5=-TACCTTCGGACGTTTGAAAGTTC-3=) and
OXA-143B (5=-TAGCTCCCAATTTCCGTTTGG-3=), and that of
the blaOXA-253 gene with primers OXA-253A (5=-AAGCCGACTT
GTTTCAAAGTCGGC-3=) and OXA-253B (5=-ACTATTCGCAT
GTTTAAGTGGCAC-3=). The corresponding genes were cloned
in the same pTOPO vector (Qiagen, Courtaboeuf, France) under
the same promoter and expressed in E. coli TOP10. MICs of the
resulting strains E. coli TOP10(pTOPO-OXA-143) and E. coli
TOP10(pTOPO-OXA-253) were determined by Etest. Compari-
son of MICs showed that OXA-253 conferred a higher level of
resistance to carbapenems to E. coli TOP10 only than that con-
ferred by OXA-143, with MICs being only 2-fold higher (Table 1).
Multilocus sequence typingwas performedusing speciﬁc primers
and conditions described in the A. baumannii multilocus sequence
type (MLST) database of the Pasteur Institute (www.pasteur.fr
/recherche/genopole/PF8/mlst/Abaumannii.html). MLST analy-
sis showed that A. baumannii 25 belonged to ST113. Until now,
this ST was not commonly recovered. Indeed, some A. baumannii
isolates belonging to ST113 have been identiﬁed in Kuwait in
2013, containing plasmids harboring the blaGES-11 carbapenemase
gene alone or coharboring the blaOXA-23 gene (10). More recently,
several A. baumannii isolates belonging to ST113 or clonal com-
plex 113 (CC113) (ST99 and ST227) were recovered from south-
east Brazil, almost the same area as the hospital of Minas Gerais
where this A. baumannii 25 isolate came from (11). Moreover,
Clímaco et al. recovered the blaOXA-143 gene from multiple STs of
carbapenem-resistant A. baumannii strains (CRABs) (ST109,
ST405, and ST406) (11), emphasizing that the dissemination of
this carbapenemase gene is not related to a single clone.
CRABs have become increasingly isolated in Brazil, with those
carrying blaOXA-23-like and blaOXA-143-like genes being most prev-
alent (11). As opposed to what occurs in the rest of the world, with
the predominance of ST92/OXA-23 A. baumannii isolates, it
seems that CRABs carrying blaOXA-23-like and blaOXA-143-like
genesmainly belong tomultiple STs and clonal complexes CC104,
CC109, and CC113 in Latin American countries.
Nucleotide sequence accession number. The nucleotide se-
quence of the blaOXA-253 gene is available under GenBank acces-
sion number KF824909.
TABLE 1 MICs of -lactams for strains tested
-Lactam(s)
MIC (g/ml)a
A. baumannii 25 A. baumannii(pOXA-253)
A. baumannii
CIP7010
E. coli
TOP10(pTOPO-OXA-253)
E. coli
TOP10(pTOPO-OXA-143)
E. coli
TOP10
Amoxicillin 256 256 32 256 256 4
Amoxicillin CLAb 256 256 32 128 64 4
Ticarcillin 256 256 8 256 128 4
Ticarcillin CLA 256 256 8 128 64 4
Piperacillin 256 256 16 8 4 1
Ceftazidime 256 4 4 0.38 0.38 0.06
Cefotaxime 256 12 2 0.12 0.12 0.12
Cefepime 4 3 2 0.12 0.12 0.12
Aztreonam 256 24 8 0.06 0.09 0.06
Imipenem 32 32 0.25 1 0.38 0.06
Ertapenem NDc ND ND 1 0.75 0.06
Meropenem 32 32 0.25 0.5 0.19 0.01
a The MICs were determined by Etest.
b CLA, clavulanic acid at a ﬁxed concentration of 4 g/ml.
c ND, not determinable due to the natural resistance of these Gram-negative rods to ertapenem.
FIG 1 Alignment of the OXA-253 amino acid sequence with that of OXA-143. Conserved residues among class D -lactamases (DBLs) are shaded. Dashes
represent conserved amino acids. -Lactamases are numbered according to the DBL numbering system (12).
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